Lee Swiderek, MD
Orthopaedic Surgery · Hermitage, TNNPI 1447679832
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,166 of the $15,489 with a category attached, or 65.6%. Smith+Nephew accounts for 68.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $11,877 and has fallen 87.9% since, to $1,438 in 2025.
Across 45 payments — averaging $344.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$11K
- Zimmer Biomet$3K
- Heraeus Medical, LLC.$1K
- Johnson & Johnson$192
- Encore Medical, LP$164
- Orthalign Inc$134
- plus $158 from 3 others
What the payments were for
- Travel & lodging$2,99219%
- Food & beverage$2,33015%
- Education$10,16666%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 7 | $10,595 |
| Zimmer Biomet | 25 | $2,970 |
| Heraeus Medical, LLC. | 2 | $1,276 |
| Johnson & Johnson | 4 | $192 |
| Encore Medical, LP | 2 | $164 |
| Orthalign Inc | 2 | $134 |
| Exactech, Inc. | 1 | $115 |
| Linvatec Corporation | 1 | $27 |
| Solventum Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PALACOS$1,276
- Journey II BCS$329
- BIRMINGHAM HIP$209
- POLARSTEM$209
- CORI$209
- Oxford$209
- DJO Surgical 3DKnee System$159
- Persona$149
- Comprehensive Shoulder System$141
- REAL INTELLIGENCE$134
- VISIONAIRE$120
- OPTETRAK$115
- ORTHALIGN PLUS$112
How this compares
$15,489 in reported general payments places this provider in the 75th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 259 | $5,875 |
| Cefadroxil | 222 | $1,465 |
| Tizanidine Hcl | 289 | $1,440 |
| Oxycodone Hcl | 157 | $1,278 |
| Mupirocin | 131 | $914 |
| Ondansetron Hcl | 162 | $318 |
| Ondansetron OdtOndansetron | 28 | $235 |
| Tramadol Hcl | 58 | $163 |
| Meloxicam | 41 | $135 |
| Amoxicillin | 56 | $50 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hermitage
- Sean KaminskyHermitage$36K
- Paul BradyKnoxville$20M
- Edwin SpencerKnoxville$2.5M
- Jesse DotyChattanooga$2.3M
- Thomas ThrockmortonGermantown$1.7M
- Alton HunterColumbia$820K
- Jefferson MorrisonNashville$678K
- Michael BeebeMemphis$626K
- Gregory PolkowskiNashville$526K
- Matthew WillisNashville$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.